T1	Participants 123 155	following total hip replacement:
T2	Participants 729 858	Between 1995 and 1996, 100 patients were randomized to receive a prophylactic therapy for prevention of heterotopic ossification.
T3	Participants 1155 1319	One hundred patients receiving no prophylactic therapy after total hip arthroplasty between 1988 and 1992 were analyzed and defined as the historical control group.
